PERITONEAL MESOTHELIOMA
Clinical trials for PERITONEAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PERITONEAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers left behind by modern medicine
Disease control Recruiting nowThis French study is testing whether a combination of two immunotherapy drugs can help control five types of advanced rare cancers that have progressed after standard treatment. It will enroll 154 adults whose cancers have specific rare origins, such as certain mesotheliomas, thy…
Matched conditions: PERITONEAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test 'Mini-Tumors' to find best heated chemo for tough cancers
Disease control Recruiting nowThis study aims to improve a treatment for cancers that have spread to the lining of the abdomen. The treatment involves surgery to remove visible tumors, followed by a wash of heated chemotherapy inside the abdomen. Researchers want to see if testing tumor samples in special lab…
Matched conditions: PERITONEAL MESOTHELIOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Lab-Grown tumor models test drugs before patients get them
Disease control Recruiting nowThis study is testing a personalized approach to treat a rare abdominal cancer called peritoneal mesothelioma. Researchers will grow a small model of a patient's tumor in the lab and test different drugs on it to see which works best before giving it to the patient. The goal is t…
Matched conditions: PERITONEAL MESOTHELIOMA
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New drug combo targets genetic weakness in tough cancers
Disease control Recruiting nowThis early-stage study is testing a new drug, IDE892, both alone and in combination with another drug called IDE397. It is for adults with advanced solid tumors that have a specific genetic change called MTAP deletion and have stopped responding to standard treatments. The main g…
Matched conditions: PERITONEAL MESOTHELIOMA
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC